Bevasiranib sodium - CAS 849758-52-7

Bevasiranib sodium, an siRNA compound, targets and silences the genes responsible for producing vascular endothelial growth factor (VEGF) . The suppression of VEGF, a critical factor in the development of choroidal neo-vascularization (CNV), aims to thwart the progression to wet age-related macular degeneration (wet AMD) .

Others, VEGFR

Others, Tyrosine Kinase/Adaptors, Angiogenesis

849699

-20°C

Ice Packs

Small Compound